BioTheryX to Participate at Upcoming Industry Conferences
SAN DIEGO, Sept. 22, 2020 /PRNewswire/ -- BioTheryX, Inc., a clinical stage biotechnology company harnessing the power of protein modulation to treat difficult diseases, today announced that Frank Mercurio, Ph.D., Chief Scientific Officer of BioTheryX, will be presenting at two upcoming industry conferences:
The 2nd European Protein Degradation Congress
Presentation: The Development of a Diverse, Cereblon-Binding Chemical Library to Deliver on the Therapeutic Potential of Targeted Protein Degradation
Date/time: September 29, 2020 at 8:40AM ET
The 3rd Annual Targeted Protein Degradation Summit
Presentation: Leveraging a Cereblon-Directed 'Molecular Glue' Library to Deliver on the Therapeutic Promise of TPD - from Immune Suppression to Immune-Oncology
Date/time: October 15, 2020 at 11:30AM ET
In addition to providing an overview of BioTheryX's proprietary small 'molecular glue' cereblon binders called Protein Homeostatic Modulators (PHMstm), which play a key role in the protein degradation process through ubiquitination offering vast therapeutic opportunities across oncology, inflammation and other diseases, Dr. Mercurio will co-chair a broader discussion group on molecular glues during the European Congress.
About BioTheryX BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to develop treatments that extend and improve the quality-of-life of patients with life-threatening diseases. Our principal technology platform centers on targeted protein degradation, as well as PHM® 'molecular glues' that enable the design of small molecules to regulate protein equilibrium. This technology utilizes the body's own protein disposal system to selectively degrade and remove disease-causing proteins. It has potential applicability to a broad range of diseases, including targets that have to date been considered 'undruggable'. For more information, please visit www.biotheryx.com.
As the graduation season approaches, COOFANDY, the modern men's essentials designer, is rolling out the red carpet for graduates with its "Style for Celebrations" theme. The brand encourages participants to share their graduation highlights using...
AI is the CIO's top priority, according to findings of Lenovo's third annual global CIO report. Inside the Tornado: How AI is Reshaping Corporate IT Today, reveals that while CIOs need to adopt and scale AI urgently, their ambitions are threatened by...
OPUS, the opportunity community for business builders, today announces a partnership with leading Dubai-based think-tank, Fiker Institute, as it launches in the...
Amkan Ventures, officially launched today and is announcing a $10M Fund of Funds (FoF) dedicated to backing emerging venture managers in the US. The new FoF is building a portfolio of a dozen funds across tech-enabled industries. Amkan Ventures...
The report titled "Building Energy Management Systems Market by Component (Hardware, Services, Software), Type (Integrated Building Energy Management Systems, Standalone Building Energy Management Systems), Application, Deployment Mode, End-Use -...
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...